revised syllabus pharmacology

8/10/2019 Revised Syllabus Pharmacology

1/15

1

DOA REMEDIOS T. ROMUALDEZ MEDICAL FOUNDATIONTACLOBAN CITY

COLLEGE OF NURSING

PHARMACOLOGY ( PETITION)

COURSE DESCRIPTION: This course deals with pharmacodynamics, pharmacokinetics,

clinical/therapeutic uses and toxicology of drugs. Emphasis is given on how a

drug works to anticipate when giving a drug to a patient are of paramount

importance since nursing responsibilities include administering drugs, calculating

medication dosages based on given setting, assessing drug effects, intervening to make a

drug more tolerable, and providing teaching about drugs and the drug regimen.

COURSE CREDIT: 3 UNITS LECTURE

CONTACT HOURS/ SEM: 54 LECTURE HOURS

PREREQUISITE: Math 1 Basic Mathematics, General Chemistry, Anatomy and Physiology, NCM 102

Fundamentals of Nursing

PLACEMENT: 2ND YEAR, 2ND SEMESTER

TERMINAL COMPETENCY: At the end of the course and given relevant actual or simulated

situations/conditions, the student will be able to:

1.

Apply concept and principles of pharmacology to ensure safe and proper use of

drugs

2.

Explain the action, therapeutic use, preparation, dosage, mode ofadministration of selected drugs and medicinal plants

3.

State precautionary measures to be observed in the administration of selected

drugs

4.

Discuss the role and responsibility of the nurse in pharmacology

5.

Interpret medication orders.

6.

Calculate medication orders based on the given setting.

INTERMEDIATE COMPETENCIES CONTENT DATE/TIME

INSTRUCTOR

Upon completion of this chapter,the students will be able to:

1.

Define the word

pharmacology.

2.

Outline the steps

involved in developing

and approving a new

drug in the United States.

3.

Describe the federal

controls on drugs that

have abuse potential.

4.

Differentiate between

generic and brand-name

drugs, over-the-counter

and prescription drugs

5.

Explain the benefits and

risks associated with the

use of over-the-counter

drugs.

I. INTRODUCTION TO PHARMACOLOGY

1. Pharmacology

2. Pharmacology and Therapeutics

3. Classification of therapeutic Agents as

Drugs, Biologics, and alternative

Therapies

4. Prescription and Over the Counter

Drugs

5. Drug Regulations and Standards

6. Sources and Evaluation of Drugs

7. Legal Regulation of Drugs

8. Drug Classes and Schedules

A. DRUG AND THE BODY

1. Pharmacokinetics

2. Pharmacodynamics

3. Factors Influencing Drug Effects

B. TOXIC EFFECTS OF DRUGS

1. Adverse Effects

June26*

1:30 -

3:00

4:30

6:00

June

27

1:30 -

3:00

MRS. ALFONSO

MRS. ALFONSO


2/15

2

INTERMEDIATE COMPETENCIES CONTENT DATE/TIME

INSTRUCTOR

Upon completion of this chapter,

the students will be able to:

1.

List the responsibilities of

the nurse in drugtherapy.

2.

Explain what is involved

in each step of the

nursing process as it

relates to drug therapy.

3.

Describe key points that

must be incorporated

into the assessment of a

patient receiving drug

therapy.

4.

Describe the essential

elements of a medication

order.

5.

Calculate the correct

dose of a drug when

given examples of drug

orders and available

forms of the drugsordered.

6.

Outline the important

points that must be

assessed and considered

before administering a

drug, combining

knowledge about the

drug with knowledge of

the patient and theenvironment.

7.

Describe the role of the

nurse and the patient in

preventing medication

errors.

2. Drug Allergy

3. Drug-Induced Tissue and Organ

Damage

C. NURSING MANAGEMENT

THE NURSING PROCESS

a. ASSESSMENT

Subjective data

a. History

- Health History Assessment Questions

Pertinent to Drug Administration

Objective Data

a. Physical Assessment

b. Laboratory Values

c. Medication Effects

b. NURSING DIAGNOSIS

c. PLANNING

d. IMPLEMENTATION

- Principles of Drug Administration

- Proper Drug Administration

- Comfort Measures

- Patient and Family Education

e. EVALUATION

D. DOSAGE CALCULATIONS

E. DRUG ADMINISTRATION THROUGHOUT

THE LIFESPAN

PHARMACOTHERAPY ACROSS THE LIFESPAN

1. PREGNANT CLIENT

2. LACTATING CLIENT

3. PEDIATRICS

4. ADULTHOOD

F. MEDICATION ERRORS AND RISKREDUCTION

1. Medication Errors

July 3

1:30 -

3:00

July 4

1:30 -

3:00

MR. NICOLAS

MRS. ALFONSO


3/15

3INTERMEDIATE COMPETENCIES CONTENT DATE/TIME INSTRUCTOR



1. List four natural body

defenses against

infection.

2. Describe the cells

associated with thebodys fight against

infection and their basic

functions.

3. Outline the sequence

of events in the

inflammatory response.

4. Correlate the events in

the inflammatory

response with the clinical

picture of inflammation.

5. Outline the sequence

of events in an antibody-

related immune reaction

and correlate these

events with the clinical

presentation of such a

reaction.

6.

Describe the sites of

action of the various anti-

inflammatory agents.

7.

Describe the therapeutic

actions, indications,pharmacokinetics,

contraindications, most

common

8.

adverse reactions, and

important drugdrug

interactions associated

with each class of

anti-inflammatory

agents.

9.

Discuss the use of anti-

inflammatory drugs

across the lifespan.

10.

Compare and contrast

the prototype drugs for

each class of anti-

inflammatory drugs with

the other drugs in that

class.

11.

Outline the nursing

considerations and

teaching needs for

patients receiving each

class of antiinflammatoryagents.

II. CONCEPT OF IMMUNOLOGY ANDINFLAMMATORY PROCESSES

THE IMMUNE SYSTEM

- Nonspecific Body Defenses and

Immune Responses

- Humoral Immunity and Antibodies- Cell mediated Immunity and Cytokines

- Nursing Process

A. IMMUNE SYSTEM MODULATORS

1. Vaccines

2. Immunostimulants

3. Immunosuppresants

CONCEPT ON INFLAMMATION

- Function of Inflammation

- Role of Histamine in Inflammation

- Histamine Receptors

- Nursing Process

B. ANTIINFLAMMATORY AGENTS

1. Nonsteroidal anti-inflammatory drugs

2. Systemic Glucocorticoids3. Antipyretics

- Mechanism of Action

- Therapeutic actions and indication

- Pharmacokinetics

- Contraindications and Cautions

- Adverse Effects

- Clinically important drug-drug

interaction

- Nursing Process

- Patient Teaching List

a. NSAIDS

JULY 10

1: 303:00

July 11*

1:303:00

4:306:00

MR. NICOLAS

MR. NICOLAS

INTERMEDIATE COMPETENCIES CONTENT DATE/TIME INSTRUCTOR

Upon completion of this chapter, C. ANTIINFECTIVE AGENTS


4/15

4


1. Explain what is meant

by selective toxicity and

discuss its importance in

anti-infective therapies.

2. Differentiate betweenbroad-spectrum and

narrow-spectrum drugs.

3. Define bacterial

resistance to antibiotics

and discuss the

emergence of resistant

strains.

4. Explain three ways to

minimize bacterial

resistance.

5. Describe three

common adverse

reactions associated with

the use of antibiotics

6.

Explain how an antibiotic

is selected for use in a

particular clinical

situation.

7.

Describe therapeutic

actions, indications,

pharmacokinetics,

contraindications, mostcommon adverse

reactions, and important

drugdrug interactions

associated with each of

the classes of antibiotics.

8.

Discuss use of antibiotics

as they are used across

the lifespan.

9.


prototype drugs for each

class of antibiotics withother drugs in that class.

10.

Outline nursing

considerations for


class of antibiotic.

1. Pathogenenicity and Virulence

2. Description and Classification of

Bacteria

3. Antiinfective Drugs

4. Acquired Resistance

5. Selection of effective antibiotics6. Host Factors

Mechanism of Action


- Pharmacokinetics


- Adverse Effects


interaction

- Nursing Process


7. Antibacterial Agents

- Penicillins

- Cephalosporins

- Tetracyclines

- Macrolides

- Aminoglycosides

- Fluoroquinolones- Sulfonamides

- Antituberculosis Agents

Mechanism of Action


- Pharmacokinetics


- Adverse Effects


interaction

- Nursing Process- Patient Teaching List



you will be able to:

D. ANTIVIRAL AGENTS July 17 MR. NICOLAS


5/15

5

1.

Discuss problems with

treating viral infections

in humans and the use

of antivirals across the

lifespan.

2.

Describe the therapeuticactions, indications,

pharmacokinetics,


common adverse



associated with each of

the types of antivirals

discussed in the chapter.

3.



each type of antiviral

with the other drugs

within that group.

4.

Outline the nursing

considerations for


class of antiviral agent.

5.

Describe the

characteristics of a

fungus and a fungalinfection.

6.

2. Discuss the

therapeutic actions,

indications,

pharmacokinetics,

contraindications,

proper administration,

most common adverse



associated with systemicand topical antifungals.

7.



systemic and topical

antifungals with the

other drugs in each

class.

8.

Discuss the impact of

using antifungals across

the lifespan.

9.

Outline the nursing

considerations for

patients receiving a

systemic or topical

antifungal.

1. Characteristics of Viruses

2. HIV/AIDS

3. General Principles of HIV

Pharmacotherapy

4. Classification of Drugs for HIV/ AIDS

- Reverse Transcriptase Inhibitors

- Protease Inhibitors5. Pharmacotherapy

a. Herpes Virus Infections

b. Influenza

c. Viral Hepatitis

Mechanism of Action


- Pharmacokinetics


- Adverse Effects


interaction

- Nursing Process


E. ANTIFUNGAL AGENTS

1. Characteristics of Fungi

2. Classifications of Mycoses3. Mechanism of Action

4. Nursing Process

5. Antifungal Agents

- Systemic

- Superficial

Mechanism of Action


- Pharmacokinetics


- Adverse Effects- Clinically important drug-drug

interaction

- Nursing Process


1:303:00


Upon completion of this chapter, F. ANTIPROTOZOAL AGENTS July 18 MR. NICOLAS


6/15

6


1.

Outline the life cycle of

the protozoan that

causes malaria.

2.


actions, indications,pharmacokinetics,

contraindications,

proper administration,

most common adverse



associated with drugs

used to treat malaria.

3.

Describe other common

protozoal infections,

including cause and

clinical presentation.

4.


the antimalarials with

other drugs used to treat

protozoal infections.

5.

Outline the nursing

considerations for

patients receiving an

antiprotozoal agent

across the lifespan

6.



pharmacokinetics,


common adverse



associated with the

anthelmintics and

antineoplastic drugs.

7.

Discuss the use ofanthelmintics and

antineoplastic drugs


8.

Outline the nursing

considerations, including

important teaching

points to stress, for


anthelmintic and

antineoplastic drugs.

a. Malarial Drugs

b. Nonmalarial Drugs

Mechanism of Action


- Pharmacokinetics

- Contraindications and Cautions- Adverse Effects


interaction

- Nursing Process


G. ANTIHELMINTIC DRUGS

H. ANTINEOPLASTIC AGENTS

1. Characteristic of Cancer: Uncontrolled

Cell Growth

2. Causes of Cancer

3. Treatment of Cancer

4. Growth Fraction and Success of

Chemotherapy

5. Special Pharmacotherapy Protocols

and Strategies for Cancer Chemotherapy

6. Toxicity of Antineoplastic Agents7. Classification of Antineoplastic Agents

Mechanism of Action


- Pharmacokinetics


- Adverse Effects


interaction

- Nursing Process


1:303:00



7/15

7



1.

Describe the anatomy

and physiology of the GI

system.

2.

Describe thepathophysiology of

Peptic Ulcer Disease.

3.



pharmacokinetics,

contraindications and

cautions, most common


important drugdrug


with laxatives,

antidiarrheal drugs,

antispasmodics and

antiemetics

4.

Discuss the use of

laxatives, antidiarrheal

drugs, antispasmodics

and antiemetics


5.

Outline the nursing


important teaching

points to stress, forpatients receiving an

laxatives, antidiarrheal

drugs, antispasmodics

and antiemetics drugs.



1.

Label a diagram showing

the glands of the

traditional endocrinesystem and list the

hormones produced by

each and its functions

2.

Describe the

pathophysiology of

diabetes mellitus,

including alterations in

metabolic pathways and

changes to basement

membranes.

3.



pharmacokinetics,


common adverse



III. CONCEPT ON METABOLIMFUNCTIONAL HEALTH PATTERN

NUTRITION AND METABOLIC PATTERN

1. Overviewa. GI System

b. Acid Production by the stomach

c. Peptic Ulcer Disease

2. Drug Therapy

a. Antiulcer Drugs

b. Laxatives

c. Antispasmodics

d. Antiemetics

Mechanism of Action


- Pharmacokinetics


- Adverse Effects


interaction

- Nursing Process


IV. THE ENDOCRINE SYSTEM ANDHOMEOSTASIS

a. Drugs acting on the Endocrine System

- Hypothalamic and Pituitary Agents

- Hypothalamic Releasing Agents

- Anterior Pituitary Hormones

b. Drug Therapy

- Growth Hormone

- Growth Hormone Antagonist- Posterior Pituitary Hormones

- Adrenocortical Agents

- Thyroid and Parathyroid Hormones

- Antidiabetic Agents

a. Glucose regulation

b. Diabetes Mellitus

c. Drug Therapy

- Insulin

- Oral Antidiabetic Agents

Mechanism of Action


- Pharmacokinetics


- Adverse Effects


interaction

- Nursing Process


July 24*

1:303:00

4:306:00

July 25

1:303:00

July 31

1:303:00

August 1

1:303:00

MRS. ALFONSO

MRS. ALFONSO

MR. NICOLAS

MR. NICOLAS



8/15

8

associated with insulin and other

antidiabetic and glucose-

elevating agents.



1.

Review the anatomy andphysiology of the kidney,

including the structure

of the nephron

2.

Describe the

pathophysiology of

Renal failure and other

renal pathology.

3.



pharmacokinetics,




important drugdrug


with the various classes

of diuretic drugs and

other urinary tract

agents.

4.

Outline the nursing


important teaching

points to stress, forpatients receiving

diuretic drugs and other

urinary tract agents .



1.

Review the anatomy

and physiology of

nervous system.

2.

2. Describe the

therapeutic actions,

indications,

pharmacokinetics,




important drugdrug



of drugs affecting the

nervous system.

V. CONCEPT OF FLUID ANDELECTROLYTES FUNCTIONAL HEALTH

PATTERN

ELIMINATION PATTERN

1. Overview of the Renal System

a. Renal absorption and Secretion

b. Fluid and Elctrolyte Balance

c. Renal Failure

2. Drug Acting on the Renal System

a. Diuretics

b. Urinary Tract Agents

c. Parenteral Fluids and Electrolytes

Mechanism of Action


- Pharmacokinetics


- Adverse Effects


interaction

- Nursing Process


VI. CONCEPT ON PERCEPTION ANDCOORDINATION

THE NERVOUS SYSTEM

a. Central Nervous System

b. Peripheral Nervous System

b.1 Autonomic Nervous System- Sympathetic

- Paraympathetic

A. DRUGS AFFECTING THE ANS

a. Adrenergic Agents

b. Adrenergic Blocking Agents

c. Cholinergic Agents

d. Cholinergic Blocking Agents

Aug 7

1:303:00

August 8

1:303:00

Aug. 14*

1:303:00

4:30- 6:00

MRS. ALFONSO

MRS. ALFONSO

MRS. ALFONSO


9/15

9INTERMEDIATE COMPETENCIES CONTENT DATE/TIME INSTRUCTOR

3. Outline the nursing


B. DRUGS ACTING ON THE CNS AND PNS

A. ANXIOLYTICS AND HYPNOTIC AGENTS

August 15

1:30- 3:00

MRS. ALFONSO


10/15

10

important teaching points, for

patients receiving

and adrenergic agent.



1.



pharmacokinetics,




important drugdrug



of psychotherapeutic

and antiepileptic agents.

2.

Outline the nursing


important teaching

points, for patients

receiving

psychotherapeutic and

antiepileptic drugs



1.


pharmacokinetics,


common adverse



associated with

antiparkinsonism and

muscle relaxant drugs.

1. States affected by anxiolytic and

hypnotic drugs

2. Drug Therapy

a. Benzodiazepines

- Antidote

b. Barbiturates

MIDTERM EXAMINATION

B. ANTIDEPRESSANT DRUGS

1. Depression and Antidepressant

2. Drug Therapy

3. Tricyclic Depressants

4. MAOIs

5. SSRIs

C. PYCHOTHERAPEUTIC AGENTS

1. Mental Disorders and their

Classification

2. Psychotherapeutic Drugs

a. Antipsychotic Neuroleptic Drugs

b. Antimanic Drugs

c. CNS Stimulants

D. ANTIEPILEPTIC DRUGS

1. Nature of Epilepsy

2. Drugs for treating Tonic-Clonic

Seizures3. Drugs for Treating Absence Seizures

Mechanism of Action


- Pharmacokinetics


- Adverse Effects


interaction

- Nursing Process


DEGENERATIVE DISEASES OF THE CENTRALNERVOUS SYSTEM

E. ANTIPARKINSONISM AGENTS

1. Parkinsonism

2. Drug Therapy

a. Anticholinergics

b. Dopaminergics

- Adjuncts to Levodopa Therapy

August 18-

23

Aug 28*

1:30- 3:00

4:306:00

August 29

1:30- 3:00

Sept 4

1:303:00

MR. NICOLAS

MR. NICOLAS

MRS. ALFONSO


2.

Discuss the use of


F. MUSCLE RELAXANTS

1. Nerves and Movements


11/15

11

muscle relaxant drugs


3.

Outline the nursing


important teaching

points to stress, forpatients receiving an


muscle relaxant drugs.



1.



pharmacokinetics,


common adverse



associated with

narcotics, antimigraine

and general and localanesthetic and

neuromuscular drugs.

2.

Discuss the use of


and general and local

anesthetic and

neuromuscular drugs


3.

Outline the nursing


important teachingpoints to stress, for



and general and local

anesthetic and

neuromuscular drugs.

2. Neuromuscular Abnormalities

3. Drug Therapy

- Centrally Acting Skeletal Muscle

Relaxants

- Direct Acting Skeletal Antispasmodic

Mechanism of Action- Therapeutic actions and indication

- Pharmacokinetics


- Adverse Effects


interaction

- Nursing Process


G. NARCOTICS AND ANTIMIGRAINE

DRUGS

1. Pain Perception

2. Migraine Headache

3. Drug Therapy

a. Narcotics

b. Opiod Receptors

c. Narcotic Agonists

d. Narcotic Agonist Antagonist

e. Narcotic Antagonist

f. Ergot Derivatives

g. Triptans

H. GENERAL AND LOCAL ANESTHETICS

1. Local Anesthesia

2. General Anesthesia

3. Drug Therapy

I. NEUROMUSCULAR AGENTS

1. Neuromuscular Junction

2. Drug Therapy

a. Nondepolarizing Neuromuscular

Junction Blockers

b. Depolarizing Neuromuscular JunctionBlockers

Sept 5

1:30 -3:00

Sept 11

1:30- 3:00

Sept 12

1:303:00

MRS. ALFONSO

MRS. ALFONSO

MR. NICOLAS



the students will be able to: VII. CONCEPTS ON OXYGENATION, Sept 18 MR. NICOLAS


12/15

12

1.

Review the anatomy and

physiology of

cardiovascular system.

2.

Describe the

pathophysiology of

hypertension.

3.


pharmacokinetics,


common adverse



associated with

antihypertensive drugs.

4.

Outline the nursing

considerations in using

antihypertensive drugs.

5.

Describe the

pathophysiology of

cardiac arrhythmias and

angina.6.



pharmacokinetics,


common adverse



associated with

antiarrhythmic and

antianginal drugs.

7.

Outline the nursingconsiderations in using

antiarrhythmic and

antianginal drugs

PERFUSION FUNCTIONAL HEALTH PATTERN

A.

DRUGS ACTING ON THE

CARDIOVASCULAR SYSTEM

1.

Overview : Cardiovascular System

2.

ANTIHYPERTENSION

a. Renin-Angiotensin System

b. Blood Pressure Control

c. Hormonal and Nervous System

Factors Influencing Blood Pressure

d. Primary Factors affecting BP

e. Drug Therapy

A. ANTIHYPERTENSIVE DRUGS

1. ACE Inhibitors

2. Angiotensin II Receptor Blocker

3. Calcium Channel Blockers

4. Vasodilators

5. Diuretics

6. Beta Blockers

7. Hypotensive Agents

B. ANTIARRHYTHMIC AGENTS

1. Overview

a. Cardiac Conductionb. Automaticity of the heart

c. Cardiac Arrhythmias

2. Drug Therapy

a. Class I: Sodium Channel Blockers

b. Class II : Beta Adrenergic Antagonist

c. Class III: Potassium Channel Blockers

d. Class IV: Calcium Channel Blockers

C. ANTIANGINAL AGENTS

1. Overviewa. Blood Supply to Myocardium

b. Coronary Artery Disease

2. Drug Therapy

a. Nitrates

b. Beta-Adrenergic Blockers

c. Calcium Channel Blockers

1:30- 3:00

Sept 19

1:303:00

MR. NICOLAS


Upon completion of this chapter, Sept. 26 MRS. ALFONSO


13/15

13


1.

Describe the

pathophysiology of

congestive heart failure

and coronary artery

disease.

2.


pharmacokinetics,


common adverse



associated with

cardiotonic and lipid

lowering agents.

3.

Outline the nursing


cardiotonic and lipid

lowering agents.

4.

Describe the coagulation

process.

5.

Describe the

pathophysiology of

anemia.

6.


pharmacokinetics,


common adverse



associated with drugs

affecting blood

coagulation and

antianemic agents.

7.

Outline the nursingconsiderations in using

drugs affecting blood

coagulation and

antianemic agents

D. CARDIOTONIC AGENTS

1. Overview

a. Cardiac Muscle Function

b. Congestive Heart Failure

2. Drug Therapy

a. Vasodilatorsb. Diuretics

c. Beta-Adrenergic Agonists

d. Cardiotonic Agents

- Cardiac Glycosides

e. Phophodiesterase Inhibitors

E. LIPID LOWERING AGENTS

1. Overview

a. Metabolism of Fats

b. Coronary Artery Disease

2. Drug Therapy

a. HMG-COA Reductase Inhibitors

b. Bile Acid Binding Agents

c. Fibric Acid Agents

d. Other Agents

F. DRUG AFFECTING BLOOD

COAGULATION

1. Overview

a. Blood Coagulation

b. Clot Resolution and Anticlotting

2. Drug Therapy: Hematopietic Growth

Factor

a. Epoetin Alfa

b. Colony Stimulating Factor

c. Platelet Enhancers

- Vitamin K: Reversing Warfarin Effects

- Protamine Sulfate: Antidote for

Heparin Overdose

- Lepirudin: Treating Heparin Allergy

G. DRUGS USED TO TREAT ANEMIA

1. Overview

a. Blood Components

b. Erythropoiesis

c. Anemia

2. Drug Therapy

a. Iron Supplement

1:303:00

Oct. 2

1:303:00

Oct 3

1:303:00

Oct 9

1:303:00

MRS. ALFONSO

MR. NICOLAS

MR. NICOLAS




H. DRUG AFFECTING THE RESPIRATORYSYSTEM

Oct. 10

1:303:00

MRS. ALFONSO


14/15

14

TOTAL OF 54 hrs( 3hrs per week except those where * ( Thursdays: 1:303:00 and 4:306:00 pm) is indicated tocomplete the total number of hours [ 54hours] in 18 weeks. )

SCHEDULE:

LECTURE DAYS: MRS.LOURADEL U. ALFONSO/ MR. HERMAN NICOLAS

THURDAYS: 1: 303: 00 pm * ( 4:306:00 pm)

FRIDAYS: 1: 303 :00 pm

REFERENCES:

1. Karch, A,. Focus on Nursing Pharmacology. 6thEd.

2. Kee, Joyce, E. Hayes, L. McCuistion, Pharmacology: A Nursing Process Approach. 7thEd.

3. Clayton, Bruce and Y. Stock, Basic Pharmacology for Nurses. 16thEd.

4. Linda Skidmore-Roth RN MSN NP. Mosby's 2014 Nursing Drug Reference. 27thEd.

5. Richard A. Lehne. Pharmacology for Nursing Care. 8

th

Ed.6. Gloria D. Pickar and Amy Pickar-Abernethy. Dosage Calculations. 9

thEd.

PREPARED BY: APPROVED BY:

MRS. LOURADEL U. ALFONSO, MAN, RN DR. SOCORRO S. GASCO, RN, DMHRMClinical Instructor Dean, College of Nursing

1.

Review the anatomy

and physiology of the

respiratory system.

2.

Describe different

respiratory pathology.

3.

Describe thetherapeutic actions,

indications,

pharmacokinetics,


common adverse

reactions, and

important drugdrug


with respiratory drugs.

4.

Outline the nursing


respiratory drugs.

1. Overview

a. Respiratory System

b. Respiratory Pathology

2. Drug Therapy

a. Bronchodilatorsb. Antiinflammatory Drugs for Asthma

c. Epectorants

d. Mucolytics

e. Antitussive Drugs

Mechanism of Action


- Pharmacokinetics


- Adverse Effects


interaction

- Nursing Process


FINAL EXAMINATION

Oct. 16

1:303:00

Oct. 17

1:303:00

Oct. 20-25

MR. NICOLAS

MR. NICOLAS


15/15

15

revised syllabus pharmacology

Documents